Sulfonylureas risk vs metformin points to clear first-line diabetes choice

http://ifttt.com/images/no_image_card.png Using sulfonylureas as a first-line treatment for diabetes is associated with an increased risk for cardiovascular disease events or death compared with the use of metformin, research shows.

Read more...